HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution.

AbstractBACKGROUND AND AIMS:
Liver fibrosis results from a prolonged wound healing response to continued injury with excessive production of extracellular proteins. In patients with chronic liver disease, the monitoring of liver fibrosis dynamics is of high interest. Whilst markers of fibrogenesis exist, markers of hepatic fibrosis resolution remain an unmet clinical need. Thus, we sought to develop an assay quantifying a circulating proteolytic fragment of cross-linked type III collagen as a biomarker of fibrolysis, testing its utility in two clinical cohorts of liver fibrosis of distinct aetiology and regressing endotype METHODS: We used a monoclonal antibody targeting the C-telopeptide of type III collagen following C-proteinase cleavage to develop and validate a neo-epitope-specific enzyme-linked immunosorbent assay (CTX-III). A potential fibrosis resolution marker, CTX-III, was measured in two clinical cohorts of patients with obesity-associated non-alcoholic fatty liver disease undergoing bariatric surgery or hepatitis C virus infection from a clinical trial study evaluating the anti-fibrotic effect of farglitazar.
RESULTS:
CTX-III was robust and specific for the targeted neo-epitope with good reproducibility in EDTA plasma. We assessed type III collagen remodelling using a panel of biomarkers, including a type III collagen formation marker (PRO-C3), degradation (C3M), and CTX-III (fibrolysis). Net fibrolysis was increased in patients with non-alcoholic fatty liver disease following bariatric surgery (p < .001). Moreover, net fibrolysis identified spontaneous fibrotic regressors from stable and progressors (p < .05 and p < .001) among hepatitis C virus infection patients.
CONCLUSION:
Circulating CTX-III as a marker of fibrolysis indicates the biomarker's beneficial use in assessing hepatic fibrosis resolution.
AuthorsMartin Pehrsson, Tina Manon-Jensen, Shu Sun, Ida F Villesen, Helena Castañé, Jorge Joven, Keyur Patel, Zachary Goodman, Mette J Nielsen, Anne-Christine Bay-Jensen, Diana J Leeming, Joachim H Mortensen, Morten A Karsdal
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 42 Issue 7 Pg. 1605-1617 (07 2022) ISSN: 1478-3231 [Electronic] United States
PMID35384259 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 Nordic Bioscience. Liver International published by John Wiley & Sons Ltd.
Chemical References
  • Biomarkers
  • Collagen Type III
  • Epitopes
  • Matrix Metalloproteinases
Topics
  • Biomarkers
  • Collagen Type III
  • Epitopes
  • Fibrosis
  • Humans
  • Liver Cirrhosis
  • Matrix Metalloproteinases
  • Non-alcoholic Fatty Liver Disease
  • Reproducibility of Results

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: